The Psychological Aspect of Polypharmacy among Patients with Chronic Diseases. A Case Control Study about the Impact of Polypharmacy Regime Amongst Patients in Kurdistan Region of Iraq

Banan Qasim Rasool,Shwan Othman Amen,Redar Amin,Gazang Noori,Ondre Ferra,Salah Kamel,Elaf Othman,Harez Fattah,Payam Maaroof,Don Eliseo Lucero‐Prisno
DOI: https://doi.org/10.31579/2637-8892/172
2022-01-01
Abstract:Background: Patients on Polypharmacy due to a chronic illness are at a higher risk of developing some form of negative psychological outcome as a result of their disease. This study aims to determine the impact of Polypharmacy on the Psychological aspect of patients living with a chronic disease. Method: A case-control study conducted among patients in an outpatient clinic of an Internist (July 1st to September 1st, of 2021) in the city of Erbil, Iraq. Data was extracted from a self-assessed questioner amongst 200 patients divided into a Polypharmacy (case group) and non-Polypharmacy group (Control group). Polypharmacy, being defined as the use of five or more medication. A ‘Hospital Anxiety and Depression Scale’ (HADS) was used to determine the presence of symptoms of depression and/or anxiety. Results: A totally of 200 patients were included in the study. Of these 100 participants were from the non-polypharmacy group while the remaining 100 were from the polypharmacy group. Of these, depression among non-polypharmacy group (control) participants were 11% while 76% were found to be non-cases of depression. Compared to that, 31% of the polypharmacy group had depression while 51% were non-cases for depression. Also. the prevalence of depression and anxiety was increasing with an increase in number of medications taken by the patients. Depression was present in 11% of patients who took 4 or less medications while the prevalence increased to 21.1%, 34.9% and 42.1% in patients who took five, six to eight, and more than nine medications, respectively Conclusion: There is a significant link between polypharmacy and psychological distress in patients with chronic diseases with a focus on depression and anxiety. Healthcare providers can help in detecting polypharmacy and in providing recommendations for simplifying medication regimes and reducing the outcomes of chronic diseases.
What problem does this paper attempt to address?